Physician profile
Abram Keating
NPI 1184700189
$4,062.45
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $971 · 2022: $910 · 2023: $1,182 · 2024: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,181.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $785.65 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $513.73 | 2021-2024 | Verquvo |
| Abbott Laboratories | $402.30 | 2021-2024 | Gallant, Assurity, Merlin@Home |
| Janssen Pharmaceuticals, INC | $365.08 | 2021-2024 | Xarelto |
| Pfizer INC. | $343.71 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $322.84 | 2021-2024 | Lifevest |
| Amgen INC. | $263.58 | 2021-2024 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $260.76 | 2021-2024 | Brilinta, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.57 | 2021-2024 | Jardiance |
| Novo Nordisk INC | $181.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $130.42 | 2024 | |
| Esperion Therapeutics, INC. | $43.78 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $42.81 | 2021-2022 | |
| Abiomed | $33.89 | 2024 | Impella |
| Atricure, INC. | $32.70 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $30.93 | 2024 | Linq II |
| Angiodynamics, INC. | $20.67 | 2024 | Auryon Laser System 100-120 Vac |
| Kiniksa Pharmaceuticals, Ltd. | $20.22 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $19.91 | 2024 | Evkeeza |
| Amarin Pharma, INC. | $19.74 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $19.17 | 2023 | Inpefa |
| Boston Scientific Corporation | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abram Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.